IP Library Granted Patent US 9,814,884
Granted Patent B2
US 9,814,884 · App. 13/669,377 · Granted Nov 14, 2017

Systems and methods for detecting faults and/or adjusting electrical therapy based on impedance changes

Inventors: Jon Parker (San Jose, CA); Andre B. Walker (Monte Sereno, CA); Udai Singh (San Francisco, CA)
Assignee: Nevro Corp.
A61N1/36142A61N1/36071A61N1/36185A61N2001/083
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,884
App. No.
13/669,377
Granted
Nov 14, 2017
Kind
B2
Abstract

System and methods for detecting impedance changes and for adjusting electrical therapy based on impedance changes are disclosed herein. A method in accordance with a particular embodiment includes applying a therapeutic, paresthesia-less electrical signal to a patient via a patient modulation system that includes a signal delivery device in electrical communication with a target neural population of the patient. The method can include monitoring on a periodic basis an impedance of an electrical circuit that includes the signal delivery device. The method can further include detecting a change in the impedance that indicates a fault and providing an indication that the fault exists.

Claims (44)

1. A method for controlling a patient therapy device, comprising:

applying a therapeutic, paresthesia-less electrical signal to a target neural population in a patient's spinal cord region via a patient modulation system that includes a signal delivery device in electrical communication with the target neural population, wherein the electrical signal provides pain relief for a period of time that extends beyond a duration of the electrical signal;

automatically monitoring, on a pre-set periodic basis, an impedance of an electrical circuit that includes the signal delivery device;

detecting a change in the impedance of the electrical circuit that indicates a fault;

automatically adjusting a compliance value in accordance with which the electrical signal is delivered; and

in response to detecting the change in the impedance automatically correcting or compensating for the fault before the patient senses a change in therapy resulting from the change in the impedance indicating the fault.

2. The method of claim 1 wherein detecting the change in impedance includes detecting the change in impedance before the patient senses a change in therapy resulting from the fault.

3. The method of claim 1 wherein the fault includes an open circuit.

4. The method of claim 1 , further comprising providing a notification of the fault before the patient senses a change in therapy resulting from the fault.

5. The method of claim 4 wherein the notification includes a vibratory signal.

6. The method of claim 4 wherein providing a notification of the fault includes directing the notification to a location external to the patient.

7. The method of claim 1 wherein automatically correcting or compensating for the fault includes checking to determine if the fault has been corrected.

8. The method of claim 1 wherein automatically correcting or compensating includes changing active contacts.

9. The method of claim 1 wherein automatically correcting or compensating includes changing a number of active contacts.

10. The method of claim 1 wherein automatically correcting or compensating for the fault includes gradually increasing a strength of the electrical signal in response to the fault being corrected.

11. The method of claim 1 , further comprising automatically adjusting a compliance margin in accordance with which the electrical signal is delivered.

12. The method of claim 1 wherein applying therapeutic, paresthesia-less electrical signals includes applying the signals at a frequency in a range of from about 1.5 kHz to about 100 kHz.

13. A method for controlling a patient therapy device, comprising:

applying a therapeutic, paresthesia-less electrical signal to a target neural population in a patient's spinal cord region via a patient modulation system that includes a signal delivery device in electrical communication with the target neural population, wherein the therapeutic electrical signal has a frequency in the range of from about 1.5 kHz to about 100 kHz and provides pain relief for a period of time that extends beyond a duration of the electrical signal;

automatically monitoring, on a pre-set periodic basis, an impedance of an electrical circuit that includes the signal delivery device;

detecting a change in the impedance of the electrical circuit that indicates a fault;

in response to detecting the change in the impedance, automatically correcting the fault before the patient senses a change in therapy resulting from the change in the impedance indicating the fault, wherein automatically correcting the fault includes—

adjusting a signal parameter of the therapeutic electrical signal from a first signal parameter value to a second signal parameter value that is greater than the first signal parameter value, and

adjusting a compliance value from a first compliance value that is less than the second signal parameter value to a second compliance value that is greater than the second signal parameter value; and automatically providing a notification of the fault.

14. A patient therapy system, comprising:

a patient-implantable portion that includes a signal generator and a signal delivery device having an electrical contact positioned to be in electrical communication with a target neural population in a patient's spinal cord region when implanted, wherein the signal generator produces an electrical signal that provides pain relief for a period of time that extends beyond a duration of the electrical signal;

an impedance detector carried by the patient-implantable portion, the impedance detector being operatively coupled to an electrical circuit that includes the electrical contact to detect an impedance of the electrical circuit; and

a processor carried by the patient-implantable portion, the processor having a computer-readable medium programmed with instructions that, when executed, perform a process that includes:

automatically monitoring, on a pre-set periodic basis, the impedance of the electrical circuit that includes the signal delivery device;

receiving an indication from the impedance detector corresponding to a fault; and

in response to receiving the indication of the fault and before the patient senses a change in therapy, automatically correcting the fault by adjusting a compliance value in accordance with which the signal generator produces the electrical signal.

15. The system of claim 14 , wherein the processor is configured to automatically correct or compensate for the fault without human intervention.

16. The system of claim 15 wherein automatically correcting or compensating includes changing a number of active contacts.

17. The method of claim 15 wherein automatically correcting or compensating includes changing active contacts.

18. The system of claim 15 , wherein adjusting a compliance value includes adjusting a compliance voltage.

19. The system of claim 15 wherein the processor is configured to:

direct the electrical signal to the electrical contact; and

gradually increase a strength of the electrical signal in response to the fault being corrected.

20. The system of claim 14 , wherein the processor is configured to determine if the fault has been corrected.

21. The system of claim 14 wherein the fault includes an open circuit.

22. The system of claim 14 , wherein the processor is configured to direct a signal providing notification of the fault.

23. The system of claim 22 wherein the processor is configured to direct a vibratory signal providing notification of the fault.

24. The system of claim wherein 22 , wherein the processor is configured to direct a signal providing notification of the fault to a location external to the patient.

25. The system of claim 14 wherein the electrical signal is a paresthesia-less, therapeutic signal at a frequency of from about 1.5 kHz to about 100 kHz.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY PREVIOUSLY RECORDED AT REEL: 029589 FRAME: 0601. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 6, 2017
From: PARKER, JON; WALKER, ANDRE B.; SINGH, UDAI
To: NEVRO CORP.
Reel/Frame 044144/0062 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2013
From: PARKER, JON; WALKER, ANDRE B.; SINGH, UDAI
To: NEVRO CORPORATION
Reel/Frame 029589/0601 →
Continuity (2)
Provisional Application 61556004 · Nov 4, 2011
Related Publication 20130116752A1 · May 9, 2013